These are the stocks posting the largest moves in premarket trading.
Check out the companies making headlines in premarket trading. Eli Lilly — The drug maker's stock surged 8% in premarket trading after the firm reported second-quarter earnings and revenue that blew past expectations. Eli Lilly also hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Under Armour — The athletics apparel stock popped 6% after posting a surprise profit of 1 cent per share.
Analysts polled by LSEG were anticipating 14 cents earned per share and $108 million in revenue. SolarEdge Technologies — The solar power products maker plunged nearly 15.9% as the stock was weighed down by its second-quarter earnings. SolarEdge reported an adjusted quarterly loss of $1.79 per share, which was wider than the loss of $1.58 per share analysts polled by LSEG had called for.
Patrick Spence Sonos Inc Dutch Bros Inc Bumble Inc Solaredge Technologies Inc Under Armour Inc Under Armour Inc Eli Lilly And Co Celsius Holdings Inc Topgolf Callaway Brands Corp Raymond James Financial Inc Piper Jaffray Companies Lattice Semiconductor Corp Fastly Inc Dividends Jfrog Ltd Klaviyo Inc Earnings Warner Bros Discovery Inc Factset Research Systems Inc Viatris Inc Market Insider Markets Economy Stock Markets Breaking News: Markets Business Business News
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Wednesday's analyst calls: Eli Lilly gets a price target increase, Goldman sees Tesla declineTesla and a pharmaceutical giant were among the stocks analysts were talking about on Wednesday.
Read more »
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.
Read more »
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate.
Read more »
Nvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall premarketNvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall premarket
Read more »
Amazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbookAmazon, Apple, Eli Lilly: Here's Morgan Stanley's earnings playbook
Read more »